Brief: Marksans Pharma Gets Final FDA Approval For Cetirizine Hydrochloride Tablets 5 Mg & 10 Mg
11/01/2022 06:56
Jan 11 (Reuters) - Marksans Pharma Ltd MARK.NS :
* ANNOUNCES FINAL APPROVAL FOR CETIRIZINE HYDROCHLORIDE
TABLETS 5
MG & 10MG FROM U.S. FDA
Source text for Eikon: ID:nBSE319W7Z
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg